209 related articles for article (PubMed ID: 23302718)
1. Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy.
Sendeyo K; Audard V; Zhang SY; Fan Q; Bouachi K; Ollero M; Rucker-Martin C; Gouadon E; Desvaux D; Bridoux F; Guellaën G; Ronco P; Lang P; Pawlak A; Sahali D
Kidney Int; 2013 Mar; 83(3):414-25. PubMed ID: 23302718
[TBL] [Abstract][Full Text] [Related]
2. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.
Chen ZH; Qin WS; Zeng CH; Zheng CX; Hong YM; Lu YZ; Li LS; Liu ZH
Kidney Int; 2010 Jun; 77(11):974-88. PubMed ID: 20375980
[TBL] [Abstract][Full Text] [Related]
3. c-mip impairs podocyte proximal signaling and induces heavy proteinuria.
Zhang SY; Kamal M; Dahan K; Pawlak A; Ory V; Desvaux D; Audard V; Candelier M; BenMohamed F; Matignon M; Christov C; Decrouy X; Bernard V; Mangiapan G; Lang P; Guellaën G; Ronco P; Sahali D
Sci Signal; 2010 May; 3(122):ra39. PubMed ID: 20484117
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
Meyer-Schwesinger C; Dehde S; Sachs M; Mathey S; Arefi K; Gatzemeier S; Balabanov S; Becker JU; Thaiss F; Meyer TN
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1015-25. PubMed ID: 22811486
[TBL] [Abstract][Full Text] [Related]
5. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
Fujino T; Hasebe N
BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
[TBL] [Abstract][Full Text] [Related]
6. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.
Peng L; Ma J; Cui R; Chen X; Wei SY; Wei QJ; Li B
PLoS One; 2014; 9(8):e106164. PubMed ID: 25165975
[TBL] [Abstract][Full Text] [Related]
7. Curcumin Improves the Renal Autophagy in Rat Experimental Membranous Nephropathy via Regulating the PI3K/AKT/mTOR and Nrf2/HO-1 Signaling Pathways.
Di Tu Q; Jin J; Hu X; Ren Y; Zhao L; He Q
Biomed Res Int; 2020; 2020():7069052. PubMed ID: 33204708
[TBL] [Abstract][Full Text] [Related]
8. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.
Ronco P; Debiec H
Semin Immunopathol; 2007 Nov; 29(4):445-58. PubMed ID: 17899086
[TBL] [Abstract][Full Text] [Related]
9. Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis.
Meyer-Schwesinger C; Dehde S; Klug P; Becker JU; Mathey S; Arefi K; Balabanov S; Venz S; Endlich KH; Pekna M; Gessner JE; Thaiss F; Meyer TN
J Immunol; 2011 Sep; 187(6):3218-29. PubMed ID: 21844386
[TBL] [Abstract][Full Text] [Related]
10. Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease.
Zhang J; Pippin JW; Vaughan MR; Krofft RD; Taniguchi Y; Romagnani P; Nelson PJ; Liu ZH; Shankland SJ
Nephron Exp Nephrol; 2012; 121(1-2):e23-37. PubMed ID: 23107969
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
[TBL] [Abstract][Full Text] [Related]
12. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
Ohse T; Vaughan MR; Kopp JB; Krofft RD; Marshall CB; Chang AM; Hudkins KL; Alpers CE; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F702-11. PubMed ID: 20007346
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular biology of membranous nephropathy.
Couser WG; Nangaku M
J Nephrol; 2006; 19(6):699-705. PubMed ID: 17173240
[TBL] [Abstract][Full Text] [Related]
14. Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy.
Gao S; Cui Z; Zhao MH
J Am Soc Nephrol; 2022 Sep; 33(9):1742-1756. PubMed ID: 35777783
[TBL] [Abstract][Full Text] [Related]
15. A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.
Ronco P; Debiec H
Pflugers Arch; 2017 Aug; 469(7-8):997-1005. PubMed ID: 28597189
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
Floege J; Kriz W; Schulze M; Susani M; Kerjaschki D; Mooney A; Couser WG; Koch KM
J Clin Invest; 1995 Dec; 96(6):2809-19. PubMed ID: 8675651
[TBL] [Abstract][Full Text] [Related]
17. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
18. Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage.
Zhao Q; Dai H; Jiang H; Zhang N; Hou F; Zheng Y; Gao Y; Liu W; Feng Z; Hu Y; Tang X; Rui H; Liu B
Biomed Pharmacother; 2024 May; 174():116583. PubMed ID: 38626520
[TBL] [Abstract][Full Text] [Related]
19. Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment.
Chung EYM; Wang YM; Keung K; Hu M; McCarthy H; Wong G; Kairaitis L; Bose B; Harris DCH; Alexander SI
Front Immunol; 2022; 13():1036249. PubMed ID: 36405681
[TBL] [Abstract][Full Text] [Related]
20. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1
Yang L; Wu Y; Lin S; Dai B; Chen H; Tao X; Li G; Wan J; Pan Y
FASEB J; 2021 Feb; 35(2):e21170. PubMed ID: 33184968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
